Get started
SYNACT PHARMA ABSS

SYNACT PHARMA AB

15.88SEKD
+0.09+0.57%
As of today at 12:19 GMT
SEK
No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Forecast Seasonals

SYNACT fundamentals

Key facts

Market capitalization‪773.85 M‬SEK
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)−2.09SEK
Founded2016
Employees (FY)6
CEOJeppe Øvli Øvlesen
Websitesynactpharma.com
About

SynAct Pharma AB engages in the development of pharmaceutical drugs for the treatment of inflammatory diseases. It also performs clinical development in order to secure proof-of-concept such as clinical relevance. The company was founded by Søren Nielsen on April 12, 2016 and is headquartered in Lund, Sweden.

Ownership
‪‪49.01 M‬‬
Free Float shares
‪‪31.71 M‬‬ (64.7%)
Closely held shares
‪‪17.30 M‬‬ (35.3%)
Free Float shares
‪‪31.71 M‬‬ (64.7%)
Closely held shares
‪‪17.30 M‬‬ (35.3%)
Capital structure
Market cap
‪‪773.85 M‬‬
Debt
‪‪1.88 M‬‬
Cash & equivalents
‪‪61.21 M‬‬
Enterprise value
‪‪714.52 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪773.85 M‬‬
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
—
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
—
Valuation ratios
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24

Growth and Profitability

Company’s recent performance and margins

Performance
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−100.00 M‬‬
‪‪−75.00 M‬‬
‪‪−50.00 M‬‬
‪‪−25.00 M‬‬
‪0.00‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−24.00 M‬‬
‪‪−18.00 M‬‬
‪‪−12.00 M‬‬
‪‪−6.00 M‬‬
‪0.00‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−20.00 M‬‬
‪‪−15.00 M‬‬
‪‪−10.00 M‬‬
‪‪−5.00 M‬‬
‪0.00‬

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
Actual
Estimate
Earnings
Next:May 27, 2025
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪−0.80‬
‪−0.60‬
‪−0.40‬
‪−0.20‬
‪0.00‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

SYNACT does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−70.00 M‬‬
‪‪−35.00 M‬‬
‪0.00‬
‪‪35.00 M‬‬
‪‪70.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪50.00 M‬‬
‪‪100.00 M‬‬
‪‪150.00 M‬‬
‪‪200.00 M‬‬
Assets
Liabilities